Highlights RxSight, Inc.

Equities

RXST

US78349D1072

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-15 EDT			5-day change	1st Jan Change
64.29 ^USD	+6.78%		+5.98%	+59.45%

05-13	RxSight Raises $115 Million From Public Offering of Shares	MT
05-07	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RxSight Raises $115 Million From Public Offering of Shares	05-13	MT
RxSight Q1 Adjusted Loss Narrows, Revenue Rises	05-07	MT
Earnings Flash (RXST) RXSIGHT Posts Q1 Revenue $29.5M, vs. Street Est of $27.6M	05-06	MT
RxSight, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-06	CI
RxSight, Inc. Increases Earnings Guidance for the Full Year 2024	05-06	CI
RxSight Launches New Light Adjustable Lens Product	04-04	MT
RxSight, Inc. Announces Commercial Launch of its Newest Light Adjustable Lens??, the LAL+??, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting	04-04	CI
RxSight's Q4 Adjusted Loss Narrows, Sales Increase; Reiterates 2024 Revenue Guidance	02-29	MT
Earnings Flash (RXST) RXSIGHT Reports Q4 Revenue $28.6M, vs. Street Est of $27.9M	02-28	MT
Rxsight, Inc. Reiterates Earnings Guidance for the Full Year 2024	02-28	CI
RxSight, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
RxSight, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-28	CI
RxSight Says It Expects Q4 Revenue to Increase 78% Year on Year; Shares Jump	01-08	MT
RxSightinc. Provides Earnings Guidance for Preliminary Unaudited Fourth Quarter 2023 , Preliminary Unaudited Fiscal Year 2023 and for Full-Year 2024	01-07	CI
Earnings Flash (RXST) RXSIGHT Reports Q3 Revenue $22.2M, vs. Street Est of $20.6M	11-09	MT
RxSight, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Rxsight, Inc. Raises Earnings Guidance for the Full Year of 2023	11-09	CI
RxSight's Q2 Adjusted Loss Narrows, Revenue Rises	23-08-08	MT
RxSight, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Earnings Flash (RXST) RXSIGHT Posts Q2 Revenue $20.8M, vs. Street Est of $19.2M	23-08-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights RxSight, Inc.

Equities

RXST

US78349D1072

Highlights

Filters